<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<style>body{background-color:white;}</style>


</head>
<body>
<style>html {
  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;
}

#ezaelorufc .gt_table {
  display: table;
  border-collapse: collapse;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: 16px;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

#ezaelorufc .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#ezaelorufc .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

#ezaelorufc .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 0;
  padding-bottom: 4px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

#ezaelorufc .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#ezaelorufc .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#ezaelorufc .gt_col_heading {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

#ezaelorufc .gt_column_spanner_outer {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

#ezaelorufc .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

#ezaelorufc .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

#ezaelorufc .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

#ezaelorufc .gt_group_heading {
  padding: 8px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
}

#ezaelorufc .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

#ezaelorufc .gt_from_md > :first-child {
  margin-top: 0;
}

#ezaelorufc .gt_from_md > :last-child {
  margin-bottom: 0;
}

#ezaelorufc .gt_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

#ezaelorufc .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 12px;
}

#ezaelorufc .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#ezaelorufc .gt_first_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
}

#ezaelorufc .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#ezaelorufc .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

#ezaelorufc .gt_striped {
  background-color: rgba(128, 128, 128, 0.05);
}

#ezaelorufc .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#ezaelorufc .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#ezaelorufc .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding: 4px;
}

#ezaelorufc .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#ezaelorufc .gt_sourcenote {
  font-size: 90%;
  padding: 4px;
}

#ezaelorufc .gt_left {
  text-align: left;
}

#ezaelorufc .gt_center {
  text-align: center;
}

#ezaelorufc .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

#ezaelorufc .gt_font_normal {
  font-weight: normal;
}

#ezaelorufc .gt_font_bold {
  font-weight: bold;
}

#ezaelorufc .gt_font_italic {
  font-style: italic;
}

#ezaelorufc .gt_super {
  font-size: 65%;
}

#ezaelorufc .gt_footnote_marks {
  font-style: italic;
  font-size: 65%;
}
</style>
<div id="ezaelorufc" style="overflow-x:auto;overflow-y:auto;width:auto;height:auto;"><table class="gt_table">
  <thead class="gt_header">
    <tr>
      <th colspan="10" class="gt_heading gt_title gt_font_normal" style>Appendix III: Key characteristics of included articles</th>
    </tr>
    <tr>
      <th colspan="10" class="gt_heading gt_subtitle gt_font_normal gt_bottom_border" style></th>
    </tr>
  </thead>
  <thead class="gt_col_headings">
    <tr>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Author (year)</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Country/countries</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Type of economic evaluation</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Setting</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Population</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Perspective</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Compared strategies</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Time horizon</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Inclusion of stochasticity</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Inclusion of AMR</th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr class="gt_group_heading_row">
      <td colspan="10" class="gt_group_heading">Trial-based analyses</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Bogdanova (2019)</td>
      <td class="gt_row gt_left">Russian federation</td>
      <td class="gt_row gt_left">CMA</td>
      <td class="gt_row gt_left">A centre dedicated to the diagnosis and treatment of TB</td>
      <td class="gt_row gt_left">All the patients diagnosed with MDR-TB</td>
      <td class="gt_row gt_left">Societal perspective, Healthcare system perspective</td>
      <td class="gt_row gt_left">LPA-based diagnostic algorithm (smear positive (SSm+) and for smear negative(SSm-) culture confirmed TB patients by Bactec MGIT or LJ; conventional culture-based algorithm (LJ–for SSm- and SSm+ patients and BacTAlert–for SSm+patients).</td>
      <td class="gt_row gt_left">TB treatment duration</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Böhmer (2002)</td>
      <td class="gt_row gt_left">Germany</td>
      <td class="gt_row gt_left">CA, CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Patients hospitalized with community-acquired pneumonia in the internal medicin department</td>
      <td class="gt_row gt_left">Healthcare centre’s perspective</td>
      <td class="gt_row gt_left">Current practice; Inquaro, a computer system to aid in diagnosing community-acquired pneumonia patients</td>
      <td class="gt_row gt_left">Hospital addmission</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Dinh (2018)</td>
      <td class="gt_row gt_left">France</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Emergency department</td>
      <td class="gt_row gt_left">Patients who consulted for community-acquired pneumonia in emergency departments</td>
      <td class="gt_row gt_left">Healthcare centre’s perspective</td>
      <td class="gt_row gt_left">Pneumococcal urinary antigen test; usual care</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Nicholson (2014)</td>
      <td class="gt_row gt_left">UK</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">People presenting to medical admissions units, or any ward accepting acute medical admissions, with an acute exacerbation of chronic cardiopulmonary illness of ≤ 168 hours’ (7 days’) duration or an acute cardiopulmonary illness of ≤ 7 days’ duration</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Point-of-care tests (POCTs) for influenza A and B and pneumococcal infection; reverse transcriptase-polymerase chain reaction (RT-PCR) tests for influenza A and B and RSV A and B; and conventional culture for these pathogens.</td>
      <td class="gt_row gt_left">28 days</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Oppong (2013)</td>
      <td class="gt_row gt_left">Norway and Sweden</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Patients aged ≥18 years presenting to their GP for the first time with an acute or worsened cough as the main or dominant symptom for up to 28 days, or who had a clinical presentation suggesting lower respiratory tract infections.</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Rapid test, point-of-care C-reactive protein.</td>
      <td class="gt_row gt_left">28 days</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Oppong (2018)</td>
      <td class="gt_row gt_left">Belgium, United Kingdom, Netherlands, Poland and Spain</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Patients presenting with respiratory tract infections in primary care, from Belgium, the Netherlands, Poland, Spain and the UK (England and Wales).</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">CRP; communication skills; CRP and communication skills combined; usual care</td>
      <td class="gt_row gt_left">28 days</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Pooran (2019)</td>
      <td class="gt_row gt_left">South Africa, Zambia, Zimbabwe, Tanzania</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Patients with presumptive tuberculosis</td>
      <td class="gt_row gt_left">Healthcare provider's perspective</td>
      <td class="gt_row gt_left">Same-day smear microscopy; POC Xpert</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Stankiewicz (2003)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">One hundred patient were evaluated for criteria meeting the subjective diagnostic criteria for chronic rhinosinusitis as developed by the Task Force for Acute and Chronic Rhinosinusitis</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Subjective-based diagnosis; diagnosed with a screening CT scan.</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Van Rie (2013)</td>
      <td class="gt_row gt_left">South Africa</td>
      <td class="gt_row gt_left">Cost Analysis</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">individuals with prolonged (&gt;2 weeks) cough and/or other TB symptoms, presenting at a primary care clinic</td>
      <td class="gt_row gt_left">Not specified</td>
      <td class="gt_row gt_left">Smear plus culture; Xpert</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Wang (2019)</td>
      <td class="gt_row gt_left">China</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Pulmonary and extrapulmonary TB suspect patients</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Single vs. repeated Xpert assay</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr class="gt_group_heading_row">
      <td colspan="10" class="gt_group_heading">Decision trees</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Abimbola (2012)</td>
      <td class="gt_row gt_left">Resource-limited countries in sub-Saharan Africa</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">A group of patients eligible for antiretroviral therapy based on the presence of clinical illness and/or a CD4 cell count of &lt;200 cells/microliter.</td>
      <td class="gt_row gt_left">Health system perspective</td>
      <td class="gt_row gt_left">Current practice (symptom screening, sputum smear microscopy, and chest radiography); culture as recommended by WHO guidelines (2007); the WHO algorithm as updated in 2011 and is based on the Xpert MTB/RIF test.</td>
      <td class="gt_row gt_left">182 days</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Ang (2015)</td>
      <td class="gt_row gt_left">Singapore</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Patients visiting an eye centre with signs suggestive of TB uveitis</td>
      <td class="gt_row gt_left">Not specified</td>
      <td class="gt_row gt_left">TST only; Interferon-gamma release assay (IGRA) following a positive TST;  IGRA only; TST and IGRA simultaneously</td>
      <td class="gt_row gt_left">30 years</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Behnamfar (2020)</td>
      <td class="gt_row gt_left">Iran</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">All the hospitalized patients between the years 2011 and 2015</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Treatment for all; no treatment; treatment based on the rapid test for a streptococcal antigen; treatment based on the culture test result; treatment based on RTA plus culture; treatment based on the RTA result, and in the case of a negative result, culturing.</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Bertran (2000)</td>
      <td class="gt_row gt_left">Spain</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care, Hospital</td>
      <td class="gt_row gt_left">Patients with CAP, less than 65 years old, without hospital admission criteria; Patients with AECB due to respiratory infection.</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Simple chest x-ray and a blood count; empirical antibiotics</td>
      <td class="gt_row gt_left">from the moment the treatment started in primary care to the final healing or clinical failure after a third antibiotic option prescribed in hospital administration</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Bonnet (2010)</td>
      <td class="gt_row gt_left">Kenya</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care/urban health clinic</td>
      <td class="gt_row gt_left">TB-suspected patients (cough of at least 2 weeks)</td>
      <td class="gt_row gt_left">Health service provider's perspective</td>
      <td class="gt_row gt_left">Bleach smear (B) and direct smear (D) (under microscope) in various combinations and orders: D1+D2; B1; B1+B2; D1+B1; B1+D2; D1+B2; D1+B1+D2; D1+D2+B2; D1+B1+B2; B1+D2+B2</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Cals (2011)</td>
      <td class="gt_row gt_left">The Netherlands</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Eligible patients were aged 18 years or older, consulting with their GP with a new episode of acute cough of up to 28 days and caused by an lower respiratory tract infections (LRTIs) in the GPs view</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">GPs managed patients in the usual care group with the availability of the Dutch College of GPs guidelines for acute cough: GP use of CRP; GP communication skills training; GP use of CRP and GP communication skills training</td>
      <td class="gt_row gt_left">28 days</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Cowan (2017)</td>
      <td class="gt_row gt_left">United States</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Inpatients placed in airborne infection isolation for presumptive pulmonary TB.</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">1 Xpert on an unconcentrated sputum sample; 1 Xpert on a concentrated sample; 2 Xperts on concentrated sputum samples; 2 smears; and 3 smears</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">de Bock (2001)</td>
      <td class="gt_row gt_left">The Netherlands</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Patients presenting with Acute sinusitis in primary care</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Wait and see; selective prescription; empirical antibiotics; ultrasound assessment; radiographic assessment</td>
      <td class="gt_row gt_left">7 days</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Dugas (2013)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CUA</td>
      <td class="gt_row gt_left">Emergency department</td>
      <td class="gt_row gt_left">Patients presenting  with symptoms of an acute respiratory infection at risk or potentially having influenza-related complications.</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">Treat none; treat based on provider judgement; treat based on a PCR-based rapid test; treat all</td>
      <td class="gt_row gt_left">Lifetime horizon</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Durski (2013)</td>
      <td class="gt_row gt_left">Uganda</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">HIV-infected adults with suspected central nervous system infections</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Comprehensive testing; stepwise testing; minimalist testing</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Giraldez-Garcia (2011)</td>
      <td class="gt_row gt_left">Spain</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Patients between the ages of 2 and 14 years who consult with a primary care physician due to AP symptoms.</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Treat all; clinical scoring; rapid testing; culture; rapid test + culture; clinical scoring + rapid test.</td>
      <td class="gt_row gt_left">1 year</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Gonzalez-Canudas (2011)</td>
      <td class="gt_row gt_left">Mexico</td>
      <td class="gt_row gt_left">CEA, BIA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Patients admitted  with suspected ILI</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">PCR; diagnosis with influenza RDT + clinical data</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Herráez (2017)</td>
      <td class="gt_row gt_left">Spain</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Patients with suspected TB</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Routine TB diagnosis; XPERT</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Holmes (2018)</td>
      <td class="gt_row gt_left">Wales, UK</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Adults with symptoms of acute respiratory tract infection (ARTI) for &gt;12 h where the antibiotic decision is unclear</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Current standard of care; antibiotic prescribing conditional on POC CRP testing.</td>
      <td class="gt_row gt_left">28 days</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Lathia (2018)</td>
      <td class="gt_row gt_left">Canada</td>
      <td class="gt_row gt_left">CMA</td>
      <td class="gt_row gt_left">Pharmacy</td>
      <td class="gt_row gt_left">Patients with sore throat</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Current standard of care; strep throat POC testing</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Lavelle (2012)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Unvaccinated children coming to a physician's office with age-appropriate symptoms of uncomplicated ILI</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">No antiviral treatment; rapid testing for influenza, followed by oseltamivir if results are positive; empiric oseltamivir treatment</td>
      <td class="gt_row gt_left">1 year</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Maizia (2011)</td>
      <td class="gt_row gt_left">France</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Adults (16 years and older) and children (up to 15 years old).</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Observation only (reference strategy); clinical scoring; RDT testing; throat culture; clinical scoring combined with RDT testing; RDT testing combined with throat culture; systematic antibiotic therapy.</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Mewes (2019)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital, ICU</td>
      <td class="gt_row gt_left">Patients with suspected sepsis on the ICU and patients hospitalized with LRTI.</td>
      <td class="gt_row gt_left">Societal perspective, Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Standard care; PCT-guided care</td>
      <td class="gt_row gt_left">The length of the hospital stay</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Michaelidis (2013)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Two hypothetical cohorts were modeled in separate trial-based analyses: adults with ARTIs judged by their physicians to require antibiotics and all adults with ARTIs.</td>
      <td class="gt_row gt_left">Health care system perspective</td>
      <td class="gt_row gt_left">Procalcitonin-guided antibiotic therapy; usual care.</td>
      <td class="gt_row gt_left">ARTI treatment episode as the time horizon</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Nelson (2015)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Emergency department</td>
      <td class="gt_row gt_left">Children presenting with ILI</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Rapid multiplex PCR; traditional PCR; direct-fluorescentantibody staining; 4: rapid antigen tests.</td>
      <td class="gt_row gt_left">Lifetime horizon</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Neuner (2003)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Adults in the general U.S. population.</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">Observation without testing or treatment; empirical treatment with penicillin; throat culture using a two-plate selective culture technique; optical immunoassay (OIA) followed by culture to confirm negative OIAtest results; OIA alone.</td>
      <td class="gt_row gt_left">1 year</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Oostenbrink (2002)</td>
      <td class="gt_row gt_left">The Netherlands</td>
      <td class="gt_row gt_left">CUA</td>
      <td class="gt_row gt_left">Hospital, Pediatric Emergency Department</td>
      <td class="gt_row gt_left">Children (1 month to 15 years) visiting the pediatric emergency department of a hospital with meningeal signs</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">Practice a lumbar puncture, based on the characteristics of the patient’s history, physical examination and serum C-reactive protein (CRP) ; do not practice this</td>
      <td class="gt_row gt_left">15 years</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Ost (2003)</td>
      <td class="gt_row gt_left">United States</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">ICU</td>
      <td class="gt_row gt_left">Immunocompetent patients in the intensive care unit</td>
      <td class="gt_row gt_left">Healthcare centre’s perspective</td>
      <td class="gt_row gt_left">Empiric treatment only; quantitative nonprotected endotracheal cultures; bronchoscopy; nonbronchoscopic mini-bronchoalveolar lavage (mini-BAL)</td>
      <td class="gt_row gt_left">28 days</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Perone (2007)</td>
      <td class="gt_row gt_left">Switzerland</td>
      <td class="gt_row gt_left">CA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">372 patients over 15 years of age who were referred for a sore throat were included between March 1999 and September 2001 if their clinical score was between two and four points.</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Rapid test systematique then antibiotic therapy if the test is positive; quick test if the score is 2 or 3 then antibiotic to patients with a positive result or a clinical basis of 4; empiric antibiotic therapy to patients with a clinical score of 3 or 4.</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Pinto (2016)</td>
      <td class="gt_row gt_left">Brazil</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Presumptive TB patients undergoing an initial consultation</td>
      <td class="gt_row gt_left">National TB programmes perspective</td>
      <td class="gt_row gt_left">Standard of care (presumptive TB patients undergoing an initial consultation, a chest X-ray, two SSM examinations and HIV testing, those with HIV co-infection undergo culture and DST); SSM testing of two samples was replaced by Xpert testing of one sputum sample</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Rodriguez‐Martinez (2019)</td>
      <td class="gt_row gt_left">Colombia</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Patients 12 months of age and younger who were admitted  for acute bronchiolitis</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">“good practice”, which included adherance to diagnosis guidelines (including: hemogram, C‐reactive protein, procalcitonin, chest radiography, and tests for detection of respiratory viruses); "bad practice"</td>
      <td class="gt_row gt_left">1.5 years</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Rothberg (2003) - 1</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CUA</td>
      <td class="gt_row gt_left">Physician's office</td>
      <td class="gt_row gt_left">Unvaccinated, healthy, working adults aged 20-50, presenting with influenza-like illness during the influenza season</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">No diagnostic test; Directigen (influenza A/B); FLU OIA; QuickVue; ZstatFlu</td>
      <td class="gt_row gt_left">5 days</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Rothberg (2003) - 2</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CUA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Persons aged &gt;65 years, presenting with influenza symptoms during the influenza season</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">Current care; Quickvue</td>
      <td class="gt_row gt_left">Lifetime horizon</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Rothberg (2005)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Healthy children at ages 2, 7 and 15 years</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">Quickvue; ZstatFlu</td>
      <td class="gt_row gt_left">Lifetime horizon</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Schuetz (2015)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">The patient population in this study is patients with suspected ARIinfection diagnoses seen in one of three settings: inpatient hospitalsetting (not in the intensive care unit - ICU); hospital ICU; outpatient clinic or emergency department (ED) based on the meta-analysis data</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">PCT testing and monitoring; usual care</td>
      <td class="gt_row gt_left">30 days</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Schwarzinger (2003)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CBA</td>
      <td class="gt_row gt_left">Primary care (not stated specifically)</td>
      <td class="gt_row gt_left">Healthy working adults younger than 65 years of age who consult within 2 days of the onset of influenza-like symptoms</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">No zanamivir; test with zanamivir; systematic zanamivir</td>
      <td class="gt_row gt_left">Duration of influenza-like illness</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Shah (2013)</td>
      <td class="gt_row gt_left">Uganda</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care, Hospital</td>
      <td class="gt_row gt_left">HIV-infected individuals presenting with signs/symptoms of active TB disease</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">ZN smear-microscopy testing of two sputa; same as 1 plus one urine sample for point-of-care LF-LAM testing; Xpert on one sputum (rifampin resistance is confirmed with conventional culture and DST for all patients); same as 3 plus one urine sample for point-of-care LF-LAM testing</td>
      <td class="gt_row gt_left">Lifetime horizon</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Shen (2016)</td>
      <td class="gt_row gt_left">China</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Children aged 18 years or below with ILI, had symptoms and signs compatible with influenza.</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">No antiviral therapy; 2: post influenza RDT treatment; 3: empiric treatment</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Siddiqui (2008)</td>
      <td class="gt_row gt_left">UK</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Patients presenting with ILI</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Do not treat with antiviral drugs; treat all patients with antiviral drugs; test then treat those who test positive</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Smith (2002)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">32-year old patients with typical influenza symptoms and a temperature 37.8°C during an influenza season. Other age categories in sensitivity analysis.</td>
      <td class="gt_row gt_left">Societal perspective, Healthcare payer's perspective</td>
      <td class="gt_row gt_left">No antiviral testing or treatment; oseltamivir/zanamivir treatment without testing; empiric rimantadine; empiric amantadine; test-treat oseltamivir/zanamivir; 6: test-treat rimantadine; 7: test-treat amantadine</td>
      <td class="gt_row gt_left">Single episode of illness</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Stojanovic (2017)</td>
      <td class="gt_row gt_left">China</td>
      <td class="gt_row gt_left">BIA</td>
      <td class="gt_row gt_left">Primary care, Emergency department, Hospital</td>
      <td class="gt_row gt_left">Patients with suspected ARI infection diagnoses seen in one of three settings (subgroups): (1) inpatient hospital setting (not in the ICU); (2) hospital ICU; (3) outpatient clinic or emergency department (ED).</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Usual care; PCT testing and monitoring</td>
      <td class="gt_row gt_left">30 days</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Takwoingi (2019)</td>
      <td class="gt_row gt_left">United Kingdom</td>
      <td class="gt_row gt_left">CUA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Adults presenting with suspected active TB</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">QFT-GIT; TSPOT.TB; reference standard (minimum set of tests defined by the NICE guideline, verified by a panel of blinded clinicians)</td>
      <td class="gt_row gt_left">60 days</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Tillekeratne (2019)</td>
      <td class="gt_row gt_left">Sri Lanka</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Emergency department</td>
      <td class="gt_row gt_left">ILI patients</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">Influenza clinical prediction tool; targeted rapid influenza testing; universal rapid influenza testing</td>
      <td class="gt_row gt_left">An ILI treatment episode</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Van Howe (2006)</td>
      <td class="gt_row gt_left">USA</td>
      <td class="gt_row gt_left">CUA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Children and adolescents presenting with pharyngitis.</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">Observe without testing or treatment; treat all suspected cases with antibiotics; treat those with positive throat cultures; treat those with positive rapid tests; treat those with positive rapid tests and those with positive throat cultures after negative rapid tests; use a clinical scoring measure to determine the diagnosis/treatment strategy.</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Vassall (2011)</td>
      <td class="gt_row gt_left">India, South Africa, Uganda</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Individuals suspected of having TB</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Two sputum microscopy, followed by clinical diagnosis that might include chest Xray and antibiotic trial; Xpert after two negative smear examinationss; Xpert instead of smear examination</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Walusimbi (2016)</td>
      <td class="gt_row gt_left">Uganda</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">The study population comprised adult HIV-infected patients older than 18 years, with presumptive active pulmonary TB</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Microscopic observation drug susceptibility (MODS) assay; Xpert MTB/Rif test.</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Xie (2017)</td>
      <td class="gt_row gt_left">Canada</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Hospitalized community acquired pneumoniae</td>
      <td class="gt_row gt_left">Healthcare centre’s perspective</td>
      <td class="gt_row gt_left">BinaxNow-SP and culture; culture alone</td>
      <td class="gt_row gt_left">3 days</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">You (2012)</td>
      <td class="gt_row gt_left">China (Hong Kong)</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Adult patients hospitalized for severe respiratory infection, suspected of influenza</td>
      <td class="gt_row gt_left">Healthcare provider</td>
      <td class="gt_row gt_left">Immunofluorescence assay; PCR testing; empirical antiviral treatment plus PCR, to later continue or discontinue treatment based on test result; empirical antiviral treatment</td>
      <td class="gt_row gt_left">Lifetime horizon</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">You (2015)</td>
      <td class="gt_row gt_left">Hong Kong (China)</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Patients hospitalized for suspected active pulmonary TB</td>
      <td class="gt_row gt_left">Healthcare provider's perspective</td>
      <td class="gt_row gt_left">Conventional approach; smear plus Xpert (for smear-negative); Xpert</td>
      <td class="gt_row gt_left">Not stated (appears to be 1 year)</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">You (2017)</td>
      <td class="gt_row gt_left">China (Hong Kong)</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Elderly patients with ILI</td>
      <td class="gt_row gt_left">Healthcare provider</td>
      <td class="gt_row gt_left">Clinical judgement without testing; rapid molecular POCT</td>
      <td class="gt_row gt_left">Lifetime horizon</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr class="gt_group_heading_row">
      <td colspan="10" class="gt_group_heading">Markov models</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Balk (2001)</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Patients with suspected, uncomplicated, community-acquired, acute bacterial sinusitis who had had symptoms for less than 4 weeks and who had not had recurrent sinusitis</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">No patients given antibiotic treatment; all patients given empirical amoxicillin treatment; patients given amoxicillin based on the results of a set of clinical criteria; patients given amoxicillin based on the results of sinus radiography (plain film x-ray)</td>
      <td class="gt_row gt_left">14 days</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Hunter (2015)</td>
      <td class="gt_row gt_left">England</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Cohorts of 100 hypothetical patients with RTI</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Current GP practice; Three strategies of CRP testing: 1) GP plus CRP; 2) Practice nurse plus CRP; 3) GP plus CRP and communicating training</td>
      <td class="gt_row gt_left">3 years</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Wikman (2017)</td>
      <td class="gt_row gt_left">Mozambique</td>
      <td class="gt_row gt_left">CUA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">TB suspects</td>
      <td class="gt_row gt_left">Healthcare provider's perspective</td>
      <td class="gt_row gt_left">Sputum smear microscopy (SM, base case); Xpert replacing SM; Xpert after smear-negative SM; microscopic observation drug-susceptibility (MODS) as a replacement; MODS as an add-on for smear-negative SM</td>
      <td class="gt_row gt_left">90 years</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr class="gt_group_heading_row">
      <td colspan="10" class="gt_group_heading">Dynamic models</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Mears (2016)</td>
      <td class="gt_row gt_left">England</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Multiple interacting components (laboratory, public health and clinical services)</td>
      <td class="gt_row gt_left">Population of England, taking into consideration the age distribution of the population and medium TB incidence</td>
      <td class="gt_row gt_left">Public sector perspective</td>
      <td class="gt_row gt_left">National TB strain typing service</td>
      <td class="gt_row gt_left">20 years</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Menzies (2012)</td>
      <td class="gt_row gt_left">Botswana, Lesotho, Namibia, South Africa, and Swaziland</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Health facility</td>
      <td class="gt_row gt_left">General population (with dynamic model). For TB diagnosis patients presenting to a health facility with suspected TB</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Current diagnostic algorithms; implementing Xpert in accordance with current WHO recommendations</td>
      <td class="gt_row gt_left">20 years</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr class="gt_group_heading_row">
      <td colspan="10" class="gt_empty_group_heading"></td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Harris (2011)</td>
      <td class="gt_row gt_left">South Africa</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care</td>
      <td class="gt_row gt_left">Ambulatory HIV-infected patients in South Africa</td>
      <td class="gt_row gt_left">Healthcare payer’s perspective</td>
      <td class="gt_row gt_left">33 diagnostic options, involving combinations of specimen collection methods (oral washes induced and expectorated sputum and bronchoalveolar lavage); PCR or clinical diagnosis with chest x-ray alone</td>
      <td class="gt_row gt_left">1 year</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Jha (2016)</td>
      <td class="gt_row gt_left">South Africa</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Laboratory</td>
      <td class="gt_row gt_left">Patients with (clinically) suspected TB</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Sputum smear microscopy alone; TBDx automated microscopy alone; TBDx automated microscopy,with confirmation of low positive results by Xpert MTB/RIF; TBDx automated microscopy, with confirmation of all positive results by Xpert MTB/RIF; Xpert MTB/RIF performed on all specimens</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Langley (2014)</td>
      <td class="gt_row gt_left">Tanzania</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Diagnostic centre</td>
      <td class="gt_row gt_left">Patients with presumptive TB - different algorithms for patients with and without HIV.</td>
      <td class="gt_row gt_left">Healthcare payer's perspective</td>
      <td class="gt_row gt_left">Ziehl-Neelsen (ZN) microscopy; LED fluorescence microscopy; same-day LED fluorescence microscopy; full Xpert rollout; Xpert for known HIV-+ cases; Xpert for HIV-+ cases with additional HIV screening; Xpert for smear-negative and known HIV-+ cases; Xpert for smear-negative and HIV-+ cases with additional HIV testing</td>
      <td class="gt_row gt_left">10 years</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Lee (2019)</td>
      <td class="gt_row gt_left">India</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Primary care, Hospital</td>
      <td class="gt_row gt_left">Adult, HIV-negative patients with presumptive/pulmonary TB</td>
      <td class="gt_row gt_left">Health system perspective</td>
      <td class="gt_row gt_left">Sputum smear microscopy; Xpert; Truenat; Truenat POC</td>
      <td class="gt_row gt_left">Lifetime horizon</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Naidoo (2016)</td>
      <td class="gt_row gt_left">South Africa</td>
      <td class="gt_row gt_left">Cost Analysis, CEA</td>
      <td class="gt_row gt_left">Laboratory</td>
      <td class="gt_row gt_left">Patients with presumptive TB</td>
      <td class="gt_row gt_left">Laboratory perspective</td>
      <td class="gt_row gt_left">A smear/culture-based algorithm; an Xpert-based algorithm</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Nshimyumukiza (2016)</td>
      <td class="gt_row gt_left">Canada</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Outpatient clinic or emergency department</td>
      <td class="gt_row gt_left">Quebec (Canada) population</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">Current care; potential rapid POC test</td>
      <td class="gt_row gt_left">1 year</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Oostenbrink (2003)</td>
      <td class="gt_row gt_left">The Netherlands</td>
      <td class="gt_row gt_left">CA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">360 children from one month up to fifteen years of age visiting the emergency department of a hospital with meningeal signs between 1988 and 1998</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Diagnostic decision rule, based on a clinical score and a CSF score (cell count in cerebrospinal fluid) for lumbar puncture and empirical treatment for bacterial meningitis; current practice (a low threshold to perform a lumbar puncture, and empirical treatment)</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Sohn (2019)</td>
      <td class="gt_row gt_left">India</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">District TB and microscopy center</td>
      <td class="gt_row gt_left">Patients presenting to care for TB diagnosis</td>
      <td class="gt_row gt_left">Healtcare system perspective</td>
      <td class="gt_row gt_left">Centralized Xpert; decentralized Xpert</td>
      <td class="gt_row gt_left">10 years</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Suen (2015)</td>
      <td class="gt_row gt_left">India</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Public sector clinics and private clinics</td>
      <td class="gt_row gt_left">Individuals are followed from birth to death, TB suspects for TB diagnosis</td>
      <td class="gt_row gt_left">Societal perspective</td>
      <td class="gt_row gt_left">current standard of care; Xpert for DST; Xpert for initial diagnoses and DST in public clinics; PPM; PPM combined with GeneXpert for DST; PPM combined with GeneXpert for initial diagnoses and DST in public clinics</td>
      <td class="gt_row gt_left">Lifetime horizon</td>
      <td class="gt_row gt_left">Yes</td>
      <td class="gt_row gt_left">Yes</td>
    </tr>
    <tr>
      <td class="gt_row gt_left">Yakhelef (2014)</td>
      <td class="gt_row gt_left">Kenya</td>
      <td class="gt_row gt_left">CEA</td>
      <td class="gt_row gt_left">Hospital</td>
      <td class="gt_row gt_left">Patients with a cough of at least 2 weeks and two negative smears</td>
      <td class="gt_row gt_left">Healthcare centre's perspective</td>
      <td class="gt_row gt_left">Conventional diagnostic algorithm (based on clinical findings, radiological features and an antibiotic trial); culture-based algorithm that uses TLA and LJ cultures in addition to the conventional algorithm</td>
      <td class="gt_row gt_left">Not reported</td>
      <td class="gt_row gt_left">No</td>
      <td class="gt_row gt_left">No</td>
    </tr>
  </tbody>
  <tfoot class="gt_sourcenotes">
    <tr>
      <td class="gt_sourcenote" colspan="10">CA: Cost Analysis; CEA: Cost-Effectiveness Analysis; CMA: Cost Minimization Analysis; CUA: Cost Utility Analysis</td>
    </tr>
  </tfoot>
  
</table></div>
</body>
</html>
